Sequential FDG-PET/CT after neoadjuvant chemotherapy is a predictor of histopathologic response in patients with head and neck squamous cell carcinoma

Molecular Imaging and Biology

Volumn 13, Issue 2, 2011, Pages 368-377

  Kikuchi, Masahiro ^a   Shinohara, Shogo ^a   Nakamoto, Yuji ^b   Usami, Yu ^a   Fujiwara, Keizo ^a   Adachi, Tsunemichi ^b   Hori, Shin Ya ^c   Tona, Yosuke ^a   Yamazaki, Hiroshi ^a   Imai, Yukihiro ^a   Naito, Yasushi ^a  

^a KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c SHIZUOKA GENERAL HOSPITAL   (Japan)

Author keywords

FDG PET CT; Head and neck squamous cell carcinoma; Histopathologic response; Neoadjuvant chemotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; NEDAPLATIN;

ACCURACY; ADULT; AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FEMALE; GASTRITIS; GASTROINTESTINAL TOXICITY; HAND FOOT SYNDROME; HEAD AND NECK CARCINOMA; HEAD AND NECK SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NEPHROTOXICITY; NEUTROPENIA; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; THROMBOCYTOPENIA; TREATMENT RESPONSE; TUMOR VOLUME;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; POSITRON-EMISSION TOMOGRAPHY; ROC CURVE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79955935673     PISSN: 15361632     EISSN: 18602002     Source Type: Journal    
DOI: 10.1007/s11307-010-0364-3     Document Type: Article

References (29)

1. Pignon JP, Bourhis J, Domenge C et al (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet 355:949-955
2. Pignon JP, le Maître A, Maillard E et al (2009) Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17, 346 patients. Radiother Oncol 92:4-14
3. The Department of Veterans Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1324:1685-1690
4. Lefebvre JL, Chevalier D, Luboinski B et al (1996) Larynx preservation in pyriform sinus cancer: preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899 (Pubitemid 26230640)
5. Ensley JF, Jacobs JR, Weaver A et al (1984) Correlation between response to cisplatinum-combination chemotherapy and subsequent radiotherapy in previously untreated patients with advanced squamous cell cancers of the head and neck. Cancer 54:811-814 (Pubitemid 14058432)
6. Therasse P, Arbuck SG, Eisenhauer EA et al (2000) New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92:205-216
7. Eisenhauer EA, Therasse P, Bogaerts J et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45:228-247
8. Veit-Haibach P, Luczak C, Wanke I et al (2007) TNM staging with FDG-PET/CT in patients with primary head and neck cancer. Eur J Nucl Med Mol Imaging 34:1953-1962 (Pubitemid 350212141)
9. Nishiyama Y, Yamamoto Y, Yokoe K et al (2005) FDG PET as a procedure for detecting simultaneous tumours in head and neck cancer patients. Nucl Med Commun 26:239-244 (Pubitemid 40411047)
10. Wartski M, Le Stanc E, Gontier E et al (2007) In search of an unknown primary tumour presenting with cervical metastases: performance of hybrid FDG-PET-CT. Nucl Med Commun 28:365-371
11. Dalsaso TA, Lowe VJ, Dunphy FR et al (2007) FDG-PET and CT in evaluation of chemotherapy in advanced head and neck cancer. Clin Positron Imaging 3:1-5
12. Andrade RS, Heron DE, Degirmenci B et al (2006) Posttreatment assessment of response using FDG-PET/CT for patients treated with definitive radiation therapy for head and neck cancers. Int J Radiat Oncol Biol Phys 65:1315-1322 (Pubitemid 44425218)
13. Weber WA, Ott K, Becker K et al (2001) Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol 19:3058-3065 (Pubitemid 32565444)
14. Ott K, Fink U, Becker K et al (2003) Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 15:4604-4610 (Pubitemid 46594034)
15. Benz MR, Czernin J, Allen-Auerbach MS et al (2009) FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas. Clin Cancer Res 15:2856-2863
16. Kodaira T, Fuwa N, Tachibana H et al (2006) Phase study of S-1 and nedaplatin for patients with recurrence of head and neck cancer. Anticancer Res 26:2265-2268 (Pubitemid 43980184)
17. Becker K, Mueller JD, Schulmacher C et al (2003) Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy. Cancer 98:1521-1530 (Pubitemid 37151509)
18. Metz CE (1989) Some practical issues of experimental design and data analysis in radiological ROC studies. Invest Radiol 24:234-245
19. Cognetti F, Pinnarò P, Carlini P et al (1988) Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer. Cancer 62:251-261
20. Cognetti F, Pinnarö P, Ruggeri EM et al (1989) Prognostic factors for chemotherapy response and survival using combination chemotherapy as initial treatment of advanced head and neck squamous cell cancer. J Clin Oncol 7:829-837 (Pubitemid 19172455)
21. Al-Kourainy K, Kish J, Ensley J et al (1987) Achievement of superior survival for histologically negative versus histologically positive clinically complete responders to cisplatin combination in patients with locally advanced head and neck cancer. Cancer 59:233-238 (Pubitemid 17232881)
22. Jacobs C, Goffinet DR, Goffinet L et al (1987) Chemotherapy as a substitute for surgery in the treatment advanced resectable head and neck cancer. A report from the Northern California Oncology Group. Cancer 60:1178-1183
23. Brun E, Kjellén E, Tennvall J et al (2002) FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 24:127-135 (Pubitemid 34111509)
24. Clark JR, Fallon BG, Dreyfuss AI et al (1988) Chemotherapeutic strategies in the multidisciplinary treatment of head and neck cancer. Semin Oncol 15:35-44
25. Yamane T, Daimaru O, Ito S et al (2004) Decreased 18F-FDG uptake 1 day after initiation of chemotherapy for malignant lymphomas. J Nucl Med 45:1838-1842 (Pubitemid 47618440)
26. Bjurberg M, Henriksson E, Brun E et al (2009) Early changes in 2-deoxy-2- [18F]fluoro-D-glucose metabolism in squamous-cell carcinoma during chemotherapy in vivo and in vitro. Cancer Biother Radiopharm 24:327-332
27. Weber WA, Wieder H (2006) Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging 33:27-37
28. Srinivas SM, Dhurairaj T, Basu S et al (2009) A recovery coefficient method for partial volume correction of PET images. Ann Nucl Med 23:341-348
29. Hawkins DS, Schuetze SM, Butrynski JE et al (2005) [18F] Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 23:8828-8834 (Pubitemid 46211529)